ERBB2 and ductal breast carcinoma in situ: Apparently, the vaccination/surgery wiped out the original HER2 positive DCIS, and a different type of tumor emerged (ER+/HER2−) by escaping the vaccine-induced immunity and led to “recurred” tumor.